top of page
  • Writer's pictureRxSense Marketing

RxSense Names Eric Slusser Chief Financial Officer

Updated: May 12

RxSense®, the healthcare technology company empowering customers with software to optimize pharmacy benefits administration and maximize prescription savings, has appointed Eric Slusser as its Chief Financial Officer.

Slusser will be responsible for overseeing all financial operations, including supporting the company’s liquidity and capital needs, and the acceleration of RxSense’s growth agenda. He will report directly to RxSense CEO and founder, Rick Bates.

Slusser is a seasoned healthcare executive who has managed all aspects of finance, including strategy, capital markets, financial reporting and planning, and brings deep experience with PBMs. This includes previously serving as CFO of Express Scripts, where he was responsible for overseeing all of finance, strategy, and acquisitions, along with the company’s Canadian PBM business. Most recently, Slusser served as CFO of Select Rehabilitation, the largest provider of contract rehabilitation and therapy services in the U.S. Slusser also previously served as CFO of Gentiva Health, a U.S. provider of home health care and hospice services, and a Fortune 1000 company.

“I’m pleased to be able to add an executive with Eric’s impressive credentials and strategic leadership to further accelerate the growth of RxSense,” said Bates. “Eric’s significant depth and breadth of experience, including serving as CFO of one the world’s largest PBMs, will be an incredible asset to our business as we enter our next growth phase in providing industry-leading technology solutions to the pharmacy ecosystem.”

“RxSense is a dynamic and diversified business with an established reputation for delivering modern solutions to the industry and lower-priced prescriptions to millions through its leading technology,” said Slusser. “I am excited to join this team and expand our rapidly growing SaaS enterprise technology and direct-to-consumer businesses, to position the company for long-term future growth.”

RxSense empowers entities across the pharmacy ecosystem with modern technology and tools to control their own pharmacy benefits – including real-time business performance analytics reporting and an adjudication platform offering complete transparency on the cost of goods and flat fee-based pricing. RxSense also provides private-label prescription discount programs to extend savings for its partners to help the patients they serve access more affordable medications.

Additionally, RxSense owns and operates SingleCare, a free prescription savings service that offers consumers fast and easy access to consistently low prices on prescription drugs. Powered by its own industry-leading technology, and through partnerships with the country’s largest pharmacies and grocers, including CVS, Walgreens, Walmart, Kroger, Albertsons, and Meijer, SingleCare improves access and adherence to affordable medications for millions of Americans. Available to use at 35,000 pharmacies nationwide, consumers can find prescription savings in 10 seconds or less through the mobile app or discount cards available on SingleCare handles hundreds of thousands of prescriptions per day and has helped millions of people across the U.S. save over $6 billion in total on their medications.

About RxSense

RxSense® is a healthcare technology company delivering industry-leading solutions for pharmacy benefits and prescription savings. The company was founded in 2015 with a vision to reinvent pharmacy benefits, and a mission to deliver solutions that lower costs on prescriptions, increase price transparency, and improve healthcare outcomes. RxSense's transformative enterprise solutions bring flexibility and efficiency to pharmacy benefit administration, serving pharmacy benefit managers, regional health plans, health systems, third party administrators, new health care and pharmacy entrants and healthcare technology companies. RxSense was named among Fast Company’s prestigious annual list of the World’s Most Innovative Companies. For more information, visit

bottom of page